Evaluation of data sources to support pharmacosurveillance

Holbrook, A. M. Evaluation of Data Sources to Support Pharmacosurveillance 8 4. FULL REPORT The “Evaluation Of Data Sources To Support Pharmacosurveillance” project explored the potential for Canada to capitalize on its internationally renowned data resources, both technical and human, to advance the assessment of benefit, harm and cost of medications. [...] Since no denominator of drug use is available to judge the frequency of the cases (which should be the numerator), no estimates of the rates of harm are obtainable. [...] These discuss the need to justify the data request, keep the collection of personal data to a minimum, ensuring a fair and informed consent, security of data and accountability for proper conduct of the research. [...] The latter include a code of conduct, usually adapted from the Canadian Standards Association Model Code for the Protection of Personal Information, leadership by health professionals and Holbrook, A. M. Evaluation of Data Sources to Support Pharmacosurveillance 13 provisions for duty of confidentiality on the part of researchers. [...] Holbrook, A. M. Evaluation of Data Sources to Support Pharmacosurveillance 26 7. Project 2. Investigation of Data Resources for Data Availability Question: Using the results of the routine pharmacosurveillance analysis from the preceding consensus conference to guide exploration of the 3 leading healthcare data resources, in each data resource: a. Does a data field exist for this information (pote